Z. Tong

发表

Fakultät für Medizin Urologische Klinik und Poliklinik Functional genomics identifies multiple clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer

J. Gschwend, R. Nawroth, P. Holm, 2019 .

Bioluminescence Imaging in the Chick Chorioallantoic Membrane Assay.

R. Nawroth, Benedict Jefferies, Z. Tong, 2020, Methods in molecular biology.

Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis

Nan Zhang, Yan He, Liang Dong, 2022, Comput. Math. Methods Medicine.

Functional genomics identifies predictive markers and clinically actionable resistance mechanisms to CDK4/6 inhibition in bladder cancer

J. Gschwend, R. Nawroth, P. Holm, 2019, Journal of Experimental & Clinical Cancer Research.

Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy

J. Gschwend, W. Schulz, R. Nawroth, 2018, PloS one.

Intravesical In Situ Immunostimulatory Gel for Triple Therapy of Bladder Cancer.

F. Xiong, Jie Tian, Wanhai Xu, 2020, ACS applied materials & interfaces.

Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer

R. Nawroth, P. Holm, J. Gschwend, 2021, Journal of personalized medicine.